ValuEngine cut shares of IntelGenx Technologies Corp. (OTCMKTS:IGXT) from a hold rating to a sell rating in a research note released on Tuesday.

Shares of IntelGenx Technologies Corp. (IGXT) opened at 0.788 on Tuesday. The stock’s market capitalization is $52.67 million. The stock’s 50 day moving average price is $0.84 and its 200 day moving average price is $0.79. IntelGenx Technologies Corp. has a 12 month low of $0.55 and a 12 month high of $1.09.

WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at

About IntelGenx Technologies Corp.

IntelGenx Technologies Corp. is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Stock Ratings for IntelGenx Technologies Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies Corp. and related stocks with our FREE daily email newsletter.